ClinicalTrials.Veeva

Menu

Short- and Long-term Outcomes of Stenting for Symptomatic Intracranial Arterial Stenosis: a Cohort Study

S

Sohag University

Status

Completed

Conditions

Intracranial Atherosclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT05203887
Soh-Med-22-01-10

Details and patient eligibility

About

The purpose of this study is to assess short and long term outcomes of stenting for symptomatic intracranial arterial stenosis.

Enrollment

43 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Participants had a symptomatic intracranial stenosis of 70-99 percentage (%) with a lesion length of ≤15 mm and target vessel diameter of ≥2.0 mm in the intracranial internal carotid, middle cerebral, intracranial vertebral or basilar arteries and the measurements of stenosis will be made on magnetic resonance angiography (MRA) using the Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) trial method and confirmed by digital subtraction angiography (DSA).
  • Presented with transient ischemic attack (TIA) or stroke within the past 12 months attributed to the stenosis.

Exclusion criteria

  • Participants with acute infarctions within the past 3 weeks.
  • Severe arterial tortuosity prevents the deployment of endovascular devices.
  • Non-atherosclerotic lesion on magnetic resonance imaging (MRI), embolic or perforator stroke on MRI or computerized tomography (CT).
  • A baseline modified Rankin Scale (mRS) score of >3.
  • Massive cerebral infarction (>1/2 middle cerebral artery (MCA) territory), intracranial hemorrhage, epidural or sub-dural hemorrhage, and intracranial brain tumor on CT or MRI scan.

Trial contacts and locations

1

Loading...

Central trial contact

Mostafa Abdelmomen Sayed, master degree

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems